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Abstract 
Research to date indicates that the number of coronary artery bypass graft (CABG) surgery patients affected by depression (i.e., major, 
minor, dysthymia) approximates between 30% and 40% of all cases. A longstanding empirical interest on psychosocial factors in CABG 
surgery patients highlights an association with increased risk of morbidity in the short and longer term. Recent evidence suggests that both 
depression and anxiety increase the risk for mortality and morbidity after CABG surgery independent of medical factors, although the 
behavioral and biological mechanisms are poorly understood. Though neither depression nor anxiety seem to markedly affect neuropsy-
chological dysfunction, depression confers a risk for incident delirium. Following a comprehensive overview of recent literature, practical 
advice is described for clinicians taking into consideration possible screening aids to improve recognition of anxiety and depression among 
CABG surgery patients. An overview of contemporary interventions and randomized, controlled trials are described, along with suggestions 
for future CABG surgery research. 
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1  Introduction  
The benefits of coronary artery bypass graft (CABG) 
surgery with respect to survival, improved ventricular function, 
freedom from angina and re-stenosis in coronary artery 
disease (CAD) populations are well established.[1] With an 
estimated 408,000 CABG surgery procedures performed in 
the USA alone, evidence suggests that between 30% and 
40% of CABG surgery patients experience a form of 
psychological depression immediately leading up to and 
after surgery.[2−6] The longstanding focus on psychosocial 
factors in CABG patients has highlighted an association 
with increased risk of morbidity in the short and longer term. 
This contemporary review describes the prevalence of depre-
ssion and anxiety symptoms, and disorders, among CABG 
surgery patients. Practical advice is described for clinicians 
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taking into consideration potential screening aids to improve 
identification of anxiety and depression among CABG patients. 
An overview of research documenting the deleterious impact 
of psychosocial factors upon cardiac and neuropsychological 
morbidity and mortality within the acute peri-operative period, 
and in the longer term, is then covered, describing possible patho- 
physiological mechanisms. Finally, current treatment intervention 
studies are described along with suggestions for future CABG 
surgery research.  
2 Depression among CABG surgery patients  
Unipolar depression is characterized by depressed mood 
and/or loss of interest or pleasure, among other symptoms. 
The reported 15% to 20% prevalence of uni-polar depression 
among CABG surgery patients is consistent with that found 
generally among cardiac patients.[7] Comparatively, the point 
prevalence among the general population is 5% to 9% for 
females and 2% to 3% among males[8] suggesting CABG  
surgery patients have higher prevalence of depression than 
community samples. Though CABG surgery is indicated for 
increasingly older patients with substantial co-morbidity in 
contemporary surgical practice, depression has surprisingly  
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been associated with patients of younger age,[9] and female 
gender.[6] Far less research has been devoted to minor depre-
ssive episodes and dysthymia, with the latter reported between 
13% and 18% of CABG surgery patients.[4,5] Collectively, 
research to date indicates the number of patients affected by 
any depression (i.e., major, minor or dysthymia) is approxi-
mately between 30% and 40% of CABG surgery patients, a 
summary of which is provided in Table 1. Studies thus far 
reporting depression prevalence are not without limitations 
and could be improved. Connerney and colleagues[2] employed 
a modified diagnostic criteria based on only several days of 
symptoms immediately post-CABG, thereby potentially inflating 
prevalence estimates. Other studies employing diagnostic 
criteria have rarely recruited more than 100 patients[3,6,10] 
while others less than 50 patients,[4,5,11] suggesting larger 
samples are required. 
Studies employing self-reported depression measurements 
suggest up to 50% of patients experience depression symp-
toms.[12–15] Wide variations in the choice of self-reporting 
measures and dichotomous cut-points to establish depression 
cases highlight how heterogeneity has contributed to unwieldy 
estimates. Studies employing self-reported measurements 
do not reflect a clinical diagnosis of depression, but rather 
depression symptoms. A lower level of depression symptoms 
after surgery may reflect the upturn in mood associated with 
improvements in physical condition from revascularization.[15] 
However, some patients may develop new depressive symptoms 
over the course of recovery from surgery.[16] McKhann et al.[15] 
showed between 13% and 9% of 124 CABG patients at one 
month and twelve month follow up, respectively, reported 
clinically relevant depressive symptoms not evident at the 
time of surgery. Peterson et al.[16] explain newly developed 
depressive symptoms resulting from the stressors of surgery 
that can produce an adjustment response, or reactive type 
depression. In any case, as described below, identifying 
depression in the CABG surgery patient is complicated by 
the somatic symptoms experienced in CAD and the physical 
stressors of surgery.  
3  Anxiety among CABG surgery patients   
Self-reporting estimates of anxiety are also variable. 
Anxiety is particularly high for CABG patients while on the 
waiting list with an unknown surgery date.[17] Fear of dying 
before, rather than during surgery, has been highlighted as a 
pervasive and anxious preoccupation.[17,18] Anxiety also 
manifests as an autonomic symptom that can exacerbate 
CAD symptoms.[19] After surgery, while anxiety may decrease 
to below pre-operative levels, the severity of anxiety does 
not necessarily remit to below sub-clinical levels and may 
warrant intervention.[20] Like depression, complicating and 
accurate identification of anxious patients over the course of 
surgery recovery is the finding that autonomic-arousal symptoms 
significantly increase after CABG.[21] This is hardly surprising 
given the overlap and seemingly indistinguishable nature of 
CAD and somatic anxiety symptoms (e.g., breathlessness, 
increased heart rate). A caveat of research to date is the use 
of non-specific self-reporting measurements that do not 
reflect the characteristics of any particular anxiety disorder, 
but rather a nebulous, often ill-defined, construct, similar to 
“stress”.[22]  
The most common anxiety disorders appear to be 
generalized anxiety disorder (GAD), a disorder marked by 
pervasive worry, and panic disorder, a disorder marked by 
recurrent panic attacks. Both GAD and panic disorder are 
variably reported from zero prevalence to nearly 11% of 
CABG surgery patients (see Table 1).[4,5,11,23] To date, emphasis 
on panic disorder and GAD is possibly the result of reco-
gnition of their higher prevalence, and also, that each disorder 
is generally associated with adverse cardiac outcomes among 
CAD patients.[24,25] With respect to other anxiety disorders 
in CABG patients, it is estimated that between 2.5% and 
Table 1. CABG studies reporting prevalence of depression and anxiety with structured diagnostic interview. 









Connerney, et al[2] 309 CABG, USA NIMH Pre 20.0 - - - - 
Kazmierski, et al[10] 260 CABG, Poland MINI Pre 6.2 - - - - 
Tully, et al[3,23] 158 CABG ± valve, Australia MINI Pre 17.1 - 0.6 10.2 10.8 
Mitchell, et al[6] 124 CABG, Canada MINI Pre 28.2 - - - - 
Fraguas, et al[4] 50 CABG, Brazil CIS Pre 8.0 6.0 - 2.0 - 
Rafanelli, et al[5] 47 CABG, Italy SCID Post (1 month) 10.6 12.8 - - 0.0 
Rothenhausler, et al[11] 34 CABG, Germany SCID Pre 2.9 17.6* 8.8 5.9 - 
*Minor depression and dysthymia. CABG: coronary artery bypass graft; CIS: clinical interview schedule; GAD: generalized anxiety disorder; MINI: Mini- 
international neuropsychiatric interview; NIMH: national institute of mental health; Pre: preoperative period; Post: postoperative period; PTSD: post traumatic 
stress disorder; SCID: structured clinical interview for DSM disorders. 
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4.3% meet the criteria for social phobia;[5,23] and between 0.6% 
and 2.1% meet criteria for obsessive compulsive disorder.[5,23] 
Less is known regarding phobic disorders among CABG 
patients and only one study reported 1.3% prevalence of 
specific phobia.[23] The above mentioned literature highlights 
the requirement for rigorous psychiatric evaluation among 
larger CABG surgery samples to determine the prevalence of 
anxiety disorders.   
Recently, particular research interest has focused on post- 
traumatic stress disorder (PTSD) in CAD and CABG surgery 
patients. One of the unique diagnostic features of PSTD is 
subjective experience or witness to, an extremely traumatic 
event.[8] An audit of 62,665 electronic medical records suggested 
post-traumatic stress disorder was prevalent in 14.7% of CABG 
patients.[26] Prospective studies with structured psychiatric 
assessments have reported far lower pre-operative levels of 
PTSD, varying between 0.6% before surgery[23]  and 9.0% 
at one month post-operatively.[5] PTSD symptomatology, 
including traumatic memories related to CABG surgery, 
was evident in up to 18% of 148 patients at six month follow- 
up.[27] As most PTSD symptoms were incident cases, the 
data suggest that exposure to the CABG surgical procedures 
and in-hospital stressors may contribute to PTSD etiology.[27] 
That being said, research among 63 Holocaust survivors 
with PTSD symptoms at the time of CABG has suggested 
that such individuals can also achieve improvements in quality 
of life despite significant preexisting PTSD symptoms.[28] 
4 Identifying depression and anxiety  
A survey of 796 cardiovascular physicians determined 
71.2% of respondents asked fewer than half of their patients 
with CAD about depression.[29] Some authors have recom-
mended depression screening following CABG surgery as a 
way to improve pathways to recovery,[30] though the American 
College of Cardiology and American Heart Association 
2004 guideline update on CABG surgery[19] highlight that 
pre-operative screening may simply sensitize staff and family 
members to post-operative distress and mood changes. The 
American Heart Association recently indicated that evidence 
exists for depression screening in CAD patients,[31] stating it 
is reasonable in instances where patients have access to case 
management, in collaboration with their primary care physi-
cian, and a mental health specialist. Thus, we strongly recomm-
ended that suitable follow-up, referral and psychosocial 
intervention pathways are in place prior to commencing 
with routine screening among CABG surgery patients. As 
such, not every cardiac surgery unit or medical centre could 
feasibly adopt a routine depression screening and follow-up 
protocol. Also, current evidence seems premature to support 
the premise that routine depression screening in CAD leads to 
an improvement in cardiac outcomes and furthermore no such 
evidence exists for anxiety. Clinicians are encouraged to prudently 
use their own judgment to consider psychiatric intervention 
for depression and anxiety disorders once identified in the 
CABG surgery patient, or any other CAD patient, regardless 
of impact upon cardiac prognosis. 
The American Heart Association has recommended self- 
reporting measures to aid rapid identification of likely 
depressed patients.[32] The Patient Health Questionnaire 
(PHQ)[33] is one such depression assessing measurement, 
available in English and Spanish, as a two-item screener 
(PHQ-2), to tap into the two requisite symptoms for a depre-
ssion or major depressive episode diagnosis, i.e., (1) little interest 
or pleasure in doing things, (2) feeling down, depressed, or 
hopeless. In its expanded form, the PHQ-9 covers the full 
spectrum of symptoms reflective of major depression as 
depicted in Table 2. As Carney and Freedland point out,[34] 
many different combinations of symptoms fulfill criteria for a 
major depressive episode. Certainly, close monitoring and 
follow-up for patients describing thoughts of death or self 
harm is strongly recommended. Shemesh et al.[35] reported 
that more than 12% of cardiovascular patients require immediate 
evaluation of suicidal thoughts and intent, reiterating the 
practical requirements for appropriate referral pathways 
following assessment.  
It has been suggested that a positive response to either of 
the PHQ-2 questions should be followed up with admini-
stration of the PHQ-9, with scores of ≥ 10 on the PHQ-9 
requiring an even more comprehensive assessment, such as 
by a psychiatrist or psychologist.[32] As previously mentioned, 
Table 2. Core depression symptoms assessed by PHQ-9. 
Over the past two weeks, how often have you been bothered by any 
of the following problems? 
1. Little interest or pleasure in doing things. 
2. Feeling down, depressed, or hopeless. 
3. Trouble falling or staying asleep, or sleeping too much. 
4. Feeling tired or having little energy. 
5. Poor appetite or overeating. 
6. Feeling bad about yourself-or that you are a failure or have let 
yourself or your family down. 
7. Trouble concentrating on things, such as reading the newspaper or 
watching television. 
8. Moving or speaking so slowly that other people could have noticed? 
Or the opposite–being so fidgety or restless that you have been 
moving around a lot more than usual. 
9. Thoughts that you would be better off dead of or hurting yourself in 
some way. 
Questions are scored: not at all = 0; several days = 1; more than half the 
days = 2; nearly every day = 3. Refer to references [33,38]. PHQ: Patient 
health questionnaire. 
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the somatic laden, depression diagnostic criteria overlap CAD 
symptoms. Specifically, fatigue, loss of appetite, psychomotor 
retardation, insomnia, and difficulty concentrating can be 
the direct physiological response to a medical illness and 
hospitalization[36] and have been documented to significantly 
increase in the first month after CABG surgery.[37] Brief 
psychological reactions to the impending stressors of surgery 
and the post-operative recovery period may spontaneously 
remit over time, thus requiring no further intervention. 
Watchful waiting, monitoring and brief support of suspected 
depressed patients might serve as a useful strategy before 
implementing psychological intervention. To aid clinicians, 
the developers of the PHQ-9 have described their own 
recommendations for what constitutes depression remission 
and treatment efficacy in primary care populations.[38] With 
respect to depression identification from self-reporting symptoms 
vs. structured psychiatric interview, the only study to employ 
receiver operating characteristics (a type of statistical analysis) 
in CABG surgery patients showed that a measure of depre-
ssion yielded an area-under curve of 0.811 and 70.4% for 
sensitivity and 77.1% for specificity in the detection of 
major depression.[39] Without more research, the utility of 
self-reporting measures to identify depression in CABG 
populations remains largely unknown.  
Identification of anxiety disorders, such as GAD, panic 
disorders and PTSD, is more complicated as each is demarcated 
by specific criteria of symptoms[8] which are currently under 
revision in anticipation of the fifth Diagnostic and Statistical 
Manual of Mental Disorders. The group that developed the 
PHQ also developed a measurement with items closely 
matching diagnostic criteria for GAD.[40] Scores of ≥ 10 on 
the GAD-7 were likely to yield a positive diagnosis. The 
GAD-7 also demonstrated sensitivity and specificity for 
identification of a range of other anxiety disorders in primary 
care patients, such as PTSD and panic disorder.[41] Moreover, 
the group further described a single question pertaining to 
panic attacks with sufficient sensitivity and specificity for 
primary care populations.[41] The question was “In the last 
four weeks, have you had an anxiety attack-suddenly feeling 
fear or panic?”.[41] As mentioned above, self-reporting measures 
are typically non-specific and do not relate to any particular 
anxiety disorder. Despite an availability of a multitude of 
anxiety questionnaires, few have been validated as screening 
tools to identify anxiety disorders in CAD. Favorable 
sensitivity (90.7%) and specificity (61.4%) was reported for 
the Hospital Anxiety and Depression Scale anxiety subscale 
scores of ≥ 8 to detect GAD.[25] A study among CABG 
surgery patients showed superior receiver operating charac-
teristics (75.0% sensitivity, 72.5% specificity; area-under 
curve of 0.795) in detection of GAD when the general 
distress scale of the Mood Anxiety Symptom Questionnaire 
was used.[39] Conversely, panic disorder was best predicted by 
somatic anxiety (75.0% sensitivity, 68.5% specificity; area-under 
curve of 0.784). Apart from a multitude of self-reporting 
anxiety measurements, more time intensive structured, clinical 
interviews are also available for a range of anxiety disorders 
that can be undertaken by a psychiatrist or psychologist.   
5 Depression, anxiety and morbidity after 
CABG surgery  
Comprehensive cardiac research has included meta-analyses 
detailing etiological and prognostic associations between 
depression, in particular, and CAD outcomes.[42,43] Recent 
depression research among CABG surgery patients are 
described in Table 3. Several earlier studies corroborate the 
association between depressive symptoms upon mortality in 
the longer term.[2,13] In a study of 309 patients at one year 
follow-up, Connerney et al.[2] reported that major depression, 
but not depressive symptoms, were associated with cardiac 
events. The authors found a more than two-fold greater risk 
for cardiac events [risk ratio = 2.31, 95% confidence interval 
(CI) 1.17–4.56] after adjustment for ejection fraction, female, 
gender, extended length of hospital stay, New York Heart 
Association class and number of revascularized vessels and 
living alone. Follow-up of these patients at ten years showed 
both depression symptoms and major depression increased 
the risk for cardiac mortality. A similar finding attributable 
to depression symptoms was reported by Blumenthal et al.[44] 
who excluded patients with a major depression and psychiatric 
diagnosis, but nevertheless found that moderate to severe 
depression symptoms were associated with increased mortality 
risk (hazard ratio = 2.4, 95%CI 1.2–4.2). Evidence also 
extends to non-fatal morbidity outcomes, where depression 
symptoms reportedly increase the risk for unplanned hospital 
readmissions,[12,45–47] cardiac events[2,48] and poorer quality 
of life.[49] Scheier et al.[50] reported depressive symptoms 
associated with surgery, CAD and wound infection resulted 
in hospital readmissions among 309 patients at six month 
follow-up. Patients reporting depressive symptoms one month 
after cardiac surgery were found to have a greater proportion 
of arrhythmias and return of angina symptoms at five year 
follow-up.[14] In a study of 963 CABG patients, improvements 
in physical health at six month follow up were lower among 
patients with depressive symptoms after adjustment for 
cardiac severity and baseline health.[51] A systematic comparison 
of depression, anxiety and stress suggested that only depression 
was consistently associated with quality of life domains 
tapping into vitality, social role functioning, physical and 
general health.[49]  
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Table 3.  Association between depression and mortality or cardiac outcome after cardiac surgery. 
Reference  Sample  Age(% 
female) 




Adjustment  Critical value HR/ OR/RR 
(95%CI) 
Baker, et al[13] 158 CAG ± 
valve, AUS 
64.6 (25.3) Median 
2 years  
All-cause mortality, 
6 (3.8) 
DASS ≥ 10 1 day preop, 
15.2%   
-  Unadjusted OR = 6.24 (95%CI 
1.18–32.98); P < 0.05 
Blumenthal, 
et al[44] 
817 CAG, USA 61 (27) Mean 
5.2 years 
All-cause mortality, 




CES-D ≥ 27 
(moderate to 
severe) 








sex, age, grafts 4 
vs. 2, DM, 
previous MI  
Adjusted moderate-severe HR = 
2.37 (95%CI 1.40–4.00); P = 
0.001 
Adjusted mild HR = 1.08 (95% CI 
0.70–1.67); P = 0.723 
Burg, et al[55] 89 CAG, USA 66.3 (0) 2 years  Cardiovascular 
mortality, 5 (5.6) 
BDI > 10  < 1 week 
preop 28.1% 




Adjusted OR = 23.16 (95%CI 
1.38–389.08); P = 0.03 
Burg, et al[45] 89 CAG, USA 65.9 (0) 6 
months 
Hospitalization for 
MI or unstable 
angina, 8 (9) 
BDI ≥ 10  < 1 week 
28.1% preop 
History of MI, 
chronic renal 
insufficiency 
χ² = 4.24, P = 0.039 
Connerney, 
et al[2] 
309 CAG, USA 63.1 (33) 12 
months  
MI, PCTA, redo,  
cardiac arrest, death 
due to cardiac 
causes, 
rehospitalization for 
angina, CHF; 42 
(14) 
BDI ≥ 10 4–10 days 
postop, 28% 
MDD, LVEF, sex, 




Adjusted RR = 1.62 (95%CI 




309 CAG, USA 63.1 (33) 12 
months 
MI, PCTA, redo, 
cardiac arrest, death 
due to cardiac 
causes, 
rehospitalization for 
angina, CHF; 42 
(14) 
DIS  4–10 days 
postop, 20.4%





Adjusted RR = 2.31(95%CI 
1.17–4.56), P = 0.01 
Connerney, 
et al[48] 




DIS 4–10 days 
postop, 20.4%
Female sex, age, 
LVEF, DM 
Adjusted HR 1.78 (95%CI 
1.04–3.04), P = 0.04  
Connerney, 
et al[48] 
309 CAG, USA 63.1 (33) Median 
9.3 years 
All cause mortality, 
117 (37.9) 
DIS 4–10 days 
postop, 20.4%
Female sex, age, 
LVEF, DM 
Adjusted HR 1.19 (95%CI 
0.78–1.82), P = 0.42 
Oxlad, et 
al[46] 
119 CAG ± 
valve, AUS  
63.3 (16.0) 6 
months 
CHD or surgery 
related readmission, 
21 (17.9) 
DASS-D ≥ 10 5–6 days 
postop, 15.7% 
CPB time  Adjusted preop HR 5.15 (95%CI 
1.45–18.28), P = 0.01 
Adjusted postop HR = 0.97 
(95%CI 0.25–3.79), P = 0.96 
Oxman, 
et al [101] 
232 CAG, AVR, 










HAM-D ≥ 9 1–2 week 
preop 21.6% 
-  χ² P = 0.07  
Phillips-Bute, 
et al[102] 
427 CAG, USA 61 (30) 2 years  Repeat CAG, PCI, 
MI, cardiac arrest, 
all-cause mortality; 
n = not stated  
CES-D >16 1 day preop 
36.8% 
None Adjusted OR = 2.6 ( 95%CI 





57.9 (33.9) 4 years  All-cause mortality, 
17 (9.4)  
BDI > 10 1–5 days preop 
44% 





57.9 (33.9) 4 years  Cardiac death, 
hospitalization for 
angina, CHF, MI, 
PTCA, cardiac 
arrest; 48 (26.2) 
BDI > 10  1–5 days preop 
44% 
DM, postop 
infection, ICU ds, 
preoperative and 
post discharge 6th 
month STAI-T, 6 
month BDI scores 
Adjusted HR = 0.980 (95% CI 
0.917–1.047), P = 0.544 
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(Table 3.  Conti) 
Reference  Sample  Age(% 
female) 




Adjustment  Critical value HR/ OR/RR 
(95%CI) 
 
Tully, et al[53] 440 CAG ± 
valve, AUS   





67 (15.2)  





CVD, PVD  
Adjusted HR = 1.61 (95% CI 
0.91–2.85), P = 0.10 





DASS-D ≥ 10 < 1 week 
preop 20.1% 
 
4 days postop 
23.5% 
Anxiety, stress, 
age, sex, LVEF, 
urgency, lung 
disease, CHF, 
DM, PVD, renal 
disease, MI < 90 
ds, HTN, CCS, 
psychoactive 
medication use 
Adjusted preop HR = 0.80 (95% 
CI 0.38–1.68), P = 0.56 
 
Adjusted postop HR = 2.06 (95% 
CI 0.97–4.40), P = 0.06 
 
Tully, et al[52] 226 CAG, AUS 63 (17) Median 
4.9 year 










4 days postop LVEF, age, 
respiratory 
disease, CHF, 
renal disease, DM 
Adjusted HR = 1.36 (95% CI 
1.02–1.82), P = 0.04 
AUS: Australia; BDI: beck depression inventory; CAG: coronary artery graft; CCS: Canadian Cardiovascular Society; CES-D: Centre for Epidemiological 
Studies-Depression; CHD: coronary heart disease; CHF: congestive heart failure; CI: confidence interval; CPB: cardiopulmonary bypass time; CVA: 
cerebrovascular accident; DASS: depression, anxiety and stress scales; DIS: diagnostic interview schedule; DM: diabetes mellitus; HAM-D: Hamilton rating 
scale for depression; HR: hazard ratio; HUN: Hungary; HTN: hypertension; ICU: intensive care unit; LOS: length of stay; LV: left ventricular; LVEF: left 
ventricular ejection fraction; MDD: major depressive disorder; MI: myocardial infarction; NYHA: New York Heart Association; OR: odds ratio; PCI: 
percutaneous coronary intervention; PCTA: percutaneous coronary transluminal angioplasty; PVD: peripheral vascular disease; RR: risk ratio; STAI-T: State 
Trait Anxiety Inventory-Trait; Preop: preoperation; Postop: postoperation. 
 
Depression sub-types have also been investigated. Extra-
polating whether the timing and course of depression influences 
post-CABG morbidity, some evidence supports that new 
onset[16,48] and persistent vs. remitted depression symptoms 
assessed by self-reporting questionnaires[44] pose a greater 
risk for mortality and cardiac morbidity than brief periods of 
depression at the time of surgery. With respect to specific 
clusters of depression symptoms, two recent studies support 
a prognostic association between cognitive depression symptoms 
(e.g., pessimism, past-failure, self-criticalness, worthlessness) 
with nearly a two-fold greater risk of cardiac morbidity and 
mortality after CABG surgery.[48,52] These findings curiously 
suggest that the adverse effects of depression after CABG 
are independent of any somatic depressive symptoms, or 
medical related co-morbidity. However, current evidence 
summarized by Carney and Freedland[34] generally does not 
confirm that any particular subtype of depression confers 
greater CAD morbidity risk. 
Depression appears to contribute only partly to increased 
risk for subsequent morbidity after CABG surgery. Not 
surprisingly, research also implicates anxiety in CABG 
surgery outcomes,[56–58] as depression and anxiety frequently 
occur in the same individual concurrently and across the 
lifespan. A study among 62,665 CABG patients showed that 
9% of cases with co-morbid PTSD and major depression 
diagnosis had a greater risk of in-hospital mortality than 
patients with either PTSD, or major depression alone.[26] 
However, electronic medical records were employed for a 
limited range of psychiatric disorders that were not verified 
with structured psychiatric interview. By contrast, studies 
that simultaneously assessed both depression and anxiety 
symptoms, reported that each negative emotional state 
portended nearly two-fold increased risk of unplanned hospital 
readmissions.[43,59] Recently, our group showed pre-operative 
anxiety was associated with greater all-cause mortality [hazard 
ratio = 1.88, 95%CI 1.12–3.17] and independent of age, renal 
disease, concomitant valve procedure, cerebrovascular disease 
and peripheral vascular disease.[53] Taking these findings 
further, we showed that anxiety increases odds for incident 
atrial fibrillation after CABG surgery.[54] Additionally, we 
found that GAD, but not major depression or panic disorder, 
was associated with acute in-hospital morbidity events, such as 
stroke, myocardial infarction and renal failure.[23] Together 
the results seem to suggest that both depression and anxiety 
have a role in post-CABG morbidity. However, focusing solely 
on depression, rather than general psychiatric distress and 
anxiety, might pose as a barrier to the identification of 
CABG surgery patients at risk of morbidity and requiring 
psychological intervention.  
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Studies to date are not without their limitations. Like 
depression-CAD studies elsewhere,[42] lack of adjustment 
for conventional cardiac risk factors, such as left ventricular 
function, pose a serious caveat to interpreting the role of 
psychosocial factors upon post CABG functioning. It is 
likely that adjustment for non-psychological morbidity risk 
factors is limited by the low number of actual morbidity 
events experienced among typically small samples with 
short follow-up.[48] Some studies have also excluded patients 
with a depression or anxiety diagnosis,[42,61] thereby precluding 
examination of a dose-response effect among the more 
distressed patients. Unfortunately, these practices tend to 
bias the results in favor of rejecting the null hypothesis and 
the resultant wide confidence intervals,[13,46,55] obscure the 
effect of study size and the biological plausibility of an 
effect for depression and anxiety. Research could be improved 
by addressing the known risk factors for postoperative 
morbidity and mortality, such as those identified by the 
Society of Thoracic Surgeons,[56] extending the length of 
patient follow-up, recruiting more patients, and employing 
structured psychiatric assessments alongside self-reported 
distress measurements.  
6 Depression, anxiety and neuropsychological 
morbidity after CABG surgery  
Systematic reviews have also identified depression as a 
predisposing factor to increase the risk for delirium among 
cardiac surgery populations.[57] In the hospitalized patient, a 
delirious state may manifest itself as a fluctuating course of 
disorientation to time, place and persons, perceptual dis-
turbances and hallucinations. Delirium is the most common 
psychiatric disorder observed upon admission to healthcare 
settings.[58] The incidence of delirium after cardiac surgery is 
reportedly between 3.1% and 50%,[10,59–64] depending on the 
timing and criteria for diagnosis. McAvay and colleagues[65] 
showed that dysphoric mood and hopelessness and depressive 
symptoms were associated with incident delirium after hospita-
lization. A prognostic study for 158 CABG patients showed 
that even when diagnostic criteria for delirium is modified 
to reduce bias from overlapping delirium-depression symptoms, 
pre-operative major depression remained associated with 
incident delirium after CABG surgery.[3] In explaining recent 
findings, Davydow[66] suggested a bidirectional relationship 
whereby persons may develop subsequent distress as a response 
to in-hospital delirium. Surprisingly, related research concerning 
depression and anxiety in post-CABG neuropsychological 
functions has produced predominantly null findings from 
relatively small samples. Though post-operative neuropsy-
chological dysfunction has been exhaustively documented,[15,67,68] 
only weak correlations have been reported between depression, 
anxiety and cognitive function in the short term[18,55] and 
long term.[15,69] At six month and five year follow-up, neither 
depression, anxiety, or stress was consistently associated 
with neuropsychological dysfunction in regression analysis 
among 75 CABG surgery and 36 control patients.[69] The 
above results suggest that while psychological factors, such 
as depression might play a role in delirium, these are not 
consistently associated with neuropsychological functions.   
7 Mechanisms of cardiopathogenesis  
An increased risk in CAD morbidity attributable to emotional 
distress is likely explained by both behavioral and biological 
mechanisms. With respect to the former, epidemiological 
surveys suggest that affective disorders are associated with 
larger body mass index, hypertension, hypercholesterolemia, 
diabetes,[70] physical inactivity[71] and regular smoking and 
nicotine dependence.[65,66] Despite a greater proportion of 
co-morbidity and clinical risk factors, patients with emotional 
distress and co-morbid CAD are also less likely to comply 
with prescribed medications, such as aspirin.[72] Psychological 
distress has also been associated with less concordance to 
exercise regimens and smoking cessation four months after 
myocardial infarction.[73]   
The biological mechanisms of cardio-pathogenesis attri-
butable to depression and anxiety are multifactorial and 
include the dysregulation of the hypothalamic-pituitary- 
adrenal axis,[69–71] reduced heart-rate-variability,[72–74] altered 
serotonergic pathways, inflammatory response[74] and altered 
platelet aggregability.[75] An earlier review suggested 20% 
of variability in CAD and depressive symptoms was attributable 
to common genetic factors and the authors speculated these 
could be related to inflammation and serotonin.[76] The 
association between depression and delirium is explained, in 
part, by common patho-physiological pathways via the 
limbic-hypothalamic-pituitary-adrenal-axis, sympathetic nervous 
system and inflammatory responses suspected to affect 
cognition, mood and motivation and induce fatigability, 
anhedonia and reduced appetite.[77] 
8 Intervention and treatment 
An encouraging 2006 survey of cardiovascular physicians 
reported nearly 50% of respondents treat the symptoms of 
depression once identified in patients with CAD.[29] With 
respect to pharmacological management, clinicians should 
be aware of the possible pro-arrhythmic and cardio-toxic 
effects of tricyclic anti-depressants in cardiac patients.[78,79] 
Selective serotonin re-uptake inhibitors (SSRI), on the other 
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hand, have been hypothesized as safe among cardiac patients 
due to the serotonin transporter affinity and attenuation of 
platelet functioning. Safety, tolerability and efficacy of SSRIs 
among cardiac patients have been reported in some studies,[80,81] 
but not others.[82–84] The possible risks attributable to SSRIs for 
CABG surgery patients specifically include increased bleeding, 
but has not been consistently supported.[85,86] One study suggested 
an increased mortality and readmission risk after CABG 
surgery attributable to SSRIs.[87] Another recent study indicated 
greater renal morbidity and ventilation times, but not greater 
mortality risk.[88] Two recent systematic reviews of randomized, 
controlled trials (RCT) in CAD patients both corroborated SSRI 
vs. placebo were not associated with reductions or increased 
risk in mortality and differential findings were reported with 
respect to hospital readmissions. One found a reduced odds 
[pooled odds ratio (OR) = 0.58, 95%CI 0.39–0.85],[89] whereas 
another review did not when applying a stringent criteria for 
properly randomized studies (risk ratio = 0.74, 95%CI 0.44– 
1.23).[90] Depression symptom efficacy for SSRI vs. placebo 
was supported by a pooled standardized mean differences of 
-0.24 (95%CI: -0.38 to -0.09).[89] 
Depression is an important predictor of participation in, 
and completion of, cardiac rehabilitation among CABG surgery 
patients and thus may form a barrier to improvements in cardiac 
functioning.[91] A diverse range of behavioral and psychological 
RCT interventions have been reported and cognitive beha-
vioral therapy or collaborative care constitutes Class IIa evidence 
(i.e., it is reasonable to administer treatment, additional studies 
with focused objectives are needed).[91] Prior to CABG surgery, 
interventions have typically focused on anxiety. A non-psycho-
logical educational intervention before surgery had little impact 
on anxiety and depression.[92] By contrast, an intervention 
consisting of information and emotional support was found 
to impact depression and anxiety in the longer term.[93] In a 
Canadian study,[94] eight weeks prior to CABG, an inter-
vention consisting of nurse initiated education and support, 
in addition to exercise training (n = 113), was not associated 
with differences in pre-surgery anxiety versus usual care (n = 
107). Post-operative interventions have typically focused on 
depression as the primary psychological factor.[95,96] Freedland 
et al.[95] compared cognitive behavior or supportive stress 
management vs usual care and found significant three month 
depression remission rates in the treatment arms (71%, 57%, 
and 33% respectively, P = 0.002). Group differences were 
sustained at nine month follow up while cognitive behavioral 
therapy intervention was found to be superior with respect 
to measures of anxiety, hopelessness, stress, and quality of 
life. An eight month, bi-weekly, nurse-led telephone delivered 
intervention for depressed patients reported modest effect 
sizes for mental health quality of life (0.30; 95%CI 0.17– 
0.52), but reported exceptionally low mental health service 
visits (4% intervention vs. 6% usual care).[96] Lie et al.[97] in 
a RCT reported no differences in quality of life or distress 
measures between patients receiving nurse-led education 
with psychological support intervention (n = 93) and patients 
receiving usual care (n = 92). However, the brief interven-
tion was restricted to four home visits at two and four weeks 
post-operatively. Significantly lower depression levels among a 
control group (n = 90) compared to an exercise and behavior 
modification group (n = 94)[98] challenge the benefits of 
components, such as behavioral activation alone, for reducing 
depressive symptoms post CABG surgery.  
The limitation of psychosocial RCTs among revasculari-
zation populations is that those patients experiencing significant 
post-operative morbidity are likely to be excluded from trial 
inclusion. Thus, less is potentially known with respect to the 
long term treatment outcomes for patients who experience 
stroke, deep sternal wound infection, sternal dehiscence, 
renal failure requiring dialysis and extended length of time 
on mechanical ventilation, or intensive care during their hospital 
stay. These moribund patients face high risks for developing 
or exacerbating psychological distress. Also, though treatment 
of affective distress is important in any context, it has not 
been sufficiently investigated whether interventions among 
cardiac patients can promote and maintain health related 
behavior change.[99] Finally, beyond clinical trials, potential 
barriers to the implementation of patient support, include 
hospital culture and psychiatry registrar or allied health 
professional workload, in addition to mental health service 
accessibility and cost, cardiologist and surgeon preference 
and overlap with cardiac rehabilitation services. 
9 Conclusions and future research directions  
How can prognostic studies using a once off assessment 
of psychiatric disorders and psychological distress show an 
increase in the risk for morbidity and mortality months and 
years after CABG surgery? The behavioral and physiological 
mechanisms, such as smoking, alcohol use, diet, compliance 
to medication and exercise regimes, along with inflammatory 
processes, are possible explanations warranting further research 
in CABG surgery cohorts. Unfortunately, contemporary under-
standings of the risks of depression and anxiety in CAD are 
constrained by a predominantly biomedical model. Further 
consideration for the interaction between these disorders 
and social factors, such as socio-economic status, ethnicity, 
living alone, social isolation, may improve our under-
standings and uncover fruitful avenues for intervention. 
Moreover, research to date appears too focused on depres-
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sion, whereas the limited studies addressing depression and 
anxiety, simultaneously, warrants further research to acquire 
and extrapolate cumulative knowledge with respect to 
psychosocial risk.[100] Collaboration between psychologists 
and psychiatric specialists with cardiac surgeons, cardiologists 
and cardiac nurses will enhance the research base and may 
lead to improved patient outcomes.   
In conclusion, between 30% and 40% of CABG surgery 
patients experience depression and anxiety disorders at rates 
significantly higher than prevalent in community samples. 
Both depression and anxiety appear to confer greater morbidity 
risks, though the behavioral and biological mechanisms are 
poorly understood. It is commonly hoped that psychosocial 
intervention might mitigate the deleterious impact of depression 
and anxiety upon subsequent morbidity and mortality. Accurate 
diagnosis and intervention among CABG surgery patients 
may impact upon distress levels and clinicians are encouraged 
to establish referral and treatment pathways for their own 
CAD patients.  
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